| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 5.11 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Recent developments in CFTR modulator drugs have had a significant transformational
effect on the treatment of individuals with Cystic Fibrosis (CF) who carry the most frequent F508del-
CFTR mutation in at least one allele. However, the clinical effects of these revolutionary drugs remain
limited by their inability to fully restore the plasma membrane (PM) stability of the rescued mutant
channels. Here, we shed new light on the molecular mechanisms behind the reduced half-life of
rescued F508del-CFTR at the PM of airway cells. We describe that YES1 protein kinase is enriched in
F508del-CFTR protein PM complexes, and that its interaction with rescued channels is mediated and
dependent on the adaptor protein YAP1. Moreover, we show that interference with this complex,
either by depletion of one of these components or inhibiting YES1 activity, is sufficient to significantly
improve the abundance and stability of modulator-rescued F508del-CFTR at the surface of airway
cells. In addition, we found that this effect was mediated by a decreased phosphorylation of the
scaffold protein SHC1, a key regulator of MAPK pathway activity. In fact, we showed that depletion
of SHC1 or inhibition of MAPK pathway signaling was sufficient to improve rescued F508del-CFTR
surface levels, whereas an ectopic increase in pathway activation downstream of SHC1, through the
use of a constitutively active H-RAS protein, abrogated the stabilizing effect of YES1 inhibition on
rescued F508del-CFTR. Taken together, our findings not only provide new mechanistic insights into
the regulation of modulator-rescued F508del-CFTR membrane stability, but also open exciting new
avenues to be further explored in CF research and treatment.
Description
(This article belongs to the Section Molecular Biology)
Keywords
Cystic Fibrosis Signaling MAPK SHC1 YES F508del-CFTR MAPK Pathway Plasma Membrane Half-life Fibrose Quística Vias de Transdução de Sinal e Patologias Associadas
Pedagogical Context
Citation
Biomolecules. 2023 Jun 6;13(6):949. doi: 10.3390/biom13060949
Publisher
MDPI
